Copyright
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Orthop. Jul 18, 2025; 16(7): 106281
Published online Jul 18, 2025. doi: 10.5312/wjo.v16.i7.106281
Published online Jul 18, 2025. doi: 10.5312/wjo.v16.i7.106281
Short-term survivorship of Truliant® total knee arthroplasty implants utilizing the American Joint Replacement Registry
Kirstin Jones, Amber M Muehlmann, Clinical Affairs, Exactech, Inc., Gainesville, FL 32653, United States
Mark Musgrave, Department of Orthopaedics, Crystal Clinic Orthopaedic Center, Fairlawn, OH 44333, United States
Colin T Penrose, Department of Orthopaedics, Midwest Center for Joint Replacement, India napolis, IN 46241, United States
Author contributions: Jones K, Musgrave M, and Penrose CT designed the research study; Jones K and Muehlmann AM performed the research and wrote the manuscript; Jones K, Muehlmann AM, Musgrave M, and Penrose CT edited the manuscript; All authors have read and approve the final manuscript.
Institutional review board statement: This study is exempt from Institutional Review Board approval as outlined in the US Code of Federal Regulations, 45 CFR 46.102.
Conflict-of-interest statement: Both Kirstin Jones and Amber M Muehlmann are paid employees of Exactech. Dr. Musgrave has no conflicts of interest to declare. Dr. Penrose is a paid consultant for Exactech.
STROBE statement: The authors have read the STROBE Statement – checklist of items, and the manuscript was prepared and revised according to the STROBE Statement – checklist of items.
Data sharing statement: No additional data are available from the authors for data sharing.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Amber M Muehlmann, PhD, Clinical Affairs, Exactech, Inc., 2320 NW 66th Court, Gainesville, FL 32653, United States. amber.muehlmann@exac.com
Received: February 21, 2025
Revised: April 28, 2025
Accepted: May 27, 2025
Published online: July 18, 2025
Processing time: 146 Days and 3.8 Hours
Revised: April 28, 2025
Accepted: May 27, 2025
Published online: July 18, 2025
Processing time: 146 Days and 3.8 Hours
Core Tip
Core Tip: Short-term data on the Truliant Total Knee System in the posterior stabilized design show it performs at least as well as the aggregate of all other posterior stabilized total knee arthroplasties performed and recorded in the American Joint Replacement Registry and Australian Orthopaedic Association National Joint Replacement Registry databases. For the Truliant cruciate retaining design, short-term data show it performs better than the aggregate of all other cruciate retaining total knee arthroplasties performed and recorded in the American Joint Replacement Registry, the Australian Orthopaedic Association National Joint Replacement Registry, and the United Kingdom's National Joint Registry databases.